Rita Mezzatesta, MD
Physical Medicine & Rehabilitation · Rome, GANPI 1265538797
Payments from drug & device makers
Across 16 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$102
- Medtronic$34
- Abbott$31
- Nevro Corp.$24
- Forte Bio-pharma LLC$20
- Saluda Medical Americas, Inc.$20
- plus $41 from 3 others
What the payments were for
- Food & beverage$273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $102 |
| Medtronic | 2 | $34 |
| Abbott | 2 | $31 |
| Nevro Corp. | 2 | $24 |
| Forte Bio-pharma LLC | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $16 |
| Amgen | 1 | $14 |
| Avanos Medical | 1 | $11 |
How this compares
$273 in reported general payments places this provider in the 50th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 148 | $54,199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,961 | $51,378 |
| OxycontinOxycodone Hcl | 42 | $30,714 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 876 | $24,156 |
| NucyntaTapentadol Hcl | 14 | $12,765 |
| Oxycodone Hcl | 522 | $10,830 |
| Buprenorphine | 28 | $6,739 |
| Fentanyl | 68 | $5,918 |
| Morphine Sulfate ErMorphine Sulfate | 251 | $5,603 |
| Gabapentin | 124 | $1,292 |
| Tizanidine Hcl | 85 | $970 |
| Pregabalin | 49 | $890 |
| Morphine Sulfate | 39 | $730 |
| Hydromorphone Hcl | 68 | $722 |
| Diclofenac Sodium | 15 | $587 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Rome
- Shereef GirgisRome$4K
- Lucie MitchellRome$3K
- Richard DonadioRome$1K
- Erik ShawAtlanta$317K
- David BurkeAtlanta$189K
- Michael SchaufeleAtlanta$179K
- John LinAtlanta$124K
- di CuiAtlanta$110K
- David Travillion SrAugusta$96K
- David TranAlpharetta$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.